Hunan Jiudian Pharmaceutical Co., Ltd.
300705.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.62B
Close$
Share Statistics
| Market cap | $5.62 Billion |
|---|---|
| Enterprise Value | $5.87 Billion |
| Dividend Yield | $0.40 (3.56%) |
| Earnings per Share | $0.96 |
| Beta | 0.01 |
| Outstanding Shares | 494,110,394 |
Return
| Return on Equity | 13.14% |
|---|---|
| Return on Assets | 8.16% |
| Return on Invested Capital | 12.11% |
Valuation & Multiples
| P/E Ratio | 16.51 |
|---|---|
| PEG | -43.62 |
| Price to Sales | 2.14 |
| Price to Book Ratio | 2.14 |
| Enterprise Value to Revenue | 2.04 |
| Enterprise Value to EBIT | 13.46 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 21, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$691.60 M
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$692.03 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Hunan Jiudian Pharmaceutical Co., Ltd.
2,298 employees
CEO: Yang Yang Hunan Jiudian Pharmaceutical Co., Ltd. is a Chinese pharmaceutical enterprise that spans the entire value chain from drug discovery and development to manufacturing and commercialization. The company's extensive product line includes med...